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The Lancet has rightly given attention to the goals of reducing the burden of maternal and
childhood undernutrition,1 focussing primarily on short-term outcomes such as infant survival
and stunting.2 However the longer-term effects on adult health of a poor start to life3 suggest a
further perspective. Developmental effects have been traditionally viewed in the context of
teratogens, prematurity and growth retardation. However, developmental plasticity operates
across the entire environmental range, from undernutrition to the excessive nutritional
environments associated with gestational diabetes or maternal obesity,4,5 leading to
multigenerational cycles of disease.6 The design of intervention strategies needs to take
account of these complexities.
Realising the potential for health improvement across the life-course requires integrating
knowledge from several disciplines. Sponsored by the Rockefeller Foundation, an
interdisciplinary meeting, representing clinicians and public health specialists from both
higher and lower income countries, developmental and evolutionary biologists, geneticists,
anthropologists and economists was held in December 2006. Our starting point was the
question: how might adopting a developmental perspective on the human life-course inform
efforts to reduce the burden of non-communicable disease, particularly for populations in
rapid nutritional transition? This paper summarises the conclusions from the ensuing
dialogue.

Individual variation in risk of chronic disease
Humans now live in evolutionarily novel environments, and mismatch between our evolved
physiological capabilities and contemporary exposures may lead to ill-health.7,8 This is
particularly relevant to food preferences and consumption and to energy expenditure, which
have changed greatly over several decades in affluent societies and more recently in lower
income countries undergoing socioeconomic improvement. Substantial variations in disease
risk exist between individuals, even in the same environment,9 as well as between
populations.10 This may have a genetic component,11,12 but experimental work in the 1970s,
followed by retrospective epidemiological cohort studies, has revealed additional non-genetic
developmental contributions to risk of later disease. Whilst caution must be exercised in
extrapolating from historical cohorts to current conditions, a wide variety of experimental,
clinical and prospective epidemiological studies show that changes in maternal or infant
nutrition can produce heritable effects on risk of chronic disease.13
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Timescales of responses to environmental change
Organisms respond to challenges over a range of timescales (Figure 1). At one extreme, rapid
and reversible homeostatic mechanisms counter an immediate challenge. Then, stressors or
exposures during critical developmental periods can affect growth, tissue differentiation and
physiological set-points, influencing responses to environmental challenges for life. Such
adaptive plasticity, mediated in part by epigenetic processes,14,15 gives advantage in
environments which change over several generations. The fidelity of cues inducing adaptive
plasticity might be enhanced by integrating the experience of recent generations, and new
evidence suggests that epigenetic mechanisms may contribute to such non-genomic
transgenerational inheritance.16,17 On a longer timescale, the genomes of populations can
change over many generations as the result of selection or drift, and increasingly there are
examples of responses to environmental change being integrated into the human genome.18,19
Clinical medicine and public health have focused largely on causation and intervention at the
short-term end of this spectrum. It is now important to consider the consequences of
developmental plasticity acting over the intermediate timescale.20

Developmental processes and longer-term outcomes
Developmental plasticity evolved because it is adaptive, promoting Darwinian fitness by
enhancing survival and reproductive success.21 Plasticity uses environmental cues, which in
mammals are transduced and buffered by the mother, to optimise the life-course strategy for
maximal fitness, both making the best of present conditions and being well prepared for the
future environment.22 The hormones and nutrients crossing the placenta can be affected by the
mother’s body composition, metabolism and longer-term lifestyle as well as by her immediate
diet and stress levels. Thus, environmental cues affecting development provide historical
information which offspring use to predict the future.23
However, there are limitations to this anticipatory strategy, especially for long-lived species
such as humans, with the result that challenges during development can induce responses
which have short-term benefits for the mother or the fetus but then longer-term costs in terms
of reduced fitness.24,25 When environmental conditions change markedly between conception
and adulthood, as has happened in most present human populations, the potential for a
substantial mismatch is especially great and this contributes to disease risk. Shift in
environmental conditions between generations may also exceed the evolved capacity for
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intergenerational transmission of information. Because in developed societies we now live on
average twice as long as did our Palaeolithic ancestors, the detrimental effects of inaccurate
predictions are more likely to be apparent.

Fitness versus health
Developmental plasticity evolved to maximize an organism’s Darwinian fitness, not
necessarily its health, and life-course strategies operate to ensure survival to reproduce rather
than longevity. Anthropological and clinical data support this concept. Women throughout
hunter-gatherer societies show an inverse relationship between age at menarche and
anticipated life span,26 and in high-income countries, lower birthweight individuals have
earlier menarche, an effect exaggerated by prepubertal weight gain.27 Although being a small
(but healthy) individual may not be a ‘disease’ outcome, it incurs costs, in lower reproductive
fitness, earnings or social status28, costs which may be – biologically if not ethically – viewed
as trade-offs for gains in survival through better match of metabolic requirements to energy
availability.
Manipulation of developmental cues might be used to shift the adaptive capacity of the
organism to cope in a later environment. This is possible experimentally (for example,
metabolic disease induced by prenatal undernutrition can be prevented by postnatal hormonal
manipulation29), but it would be premature to recommend prenatal diets with a view to
promoting human offspring health. The impact of multiple micronutrients on fetal growth30
and birth outcomes31 suggests that factors other than energy and protein intake in pregnancy
may be important. Postnatal plasticity may explain the long-term differences in outcome –
metabolic and cognitive – for infants fed by breast versus formula.32,33

Implications for human health and wellbeing
An improved understanding of adaptive developmental plasticity has three important
implications for public health. First, interventions to improve adult health may need to start
early in life and to take a cross-generational perspective, challenging though this is to
policymakers and funders. Interventions starting in adult life need to take account of
developmental history – for example, attempts to change health behaviours in adults may be
less effective in populations which have, through adaptive responses to past environments of
food insecurity, developed tendencies to excessive fat storage. Secondly, it must be
5

recognized that interventions in early life aimed at essential short-term gain, such as infant
survival, may also have longer term effects on individuals throughout their life course, and
that such effects may not always be beneficial. Programmes aimed at increasing birth weight
may increase the risk of later diabetes, amplified by accelerated fat gain in childhood, a
possible consequence of universal supplementation programmes.34 Thirdly, recent drives to
develop one uniform standard for human growth35 assume that optimal health across the life
course will be achieved through comparable growth in a variety of settings, irrespective of
factors such as maternal diet, body composition or physical activity. The best outcome
measure for postnatal growth remains uncertain – Black et al36 in the recent Lancet series
proposed stunting (height-for-age) as a better indicator of undernutrition than underweight
(weight-for-age) but in turn this assumes that the only outcome associated with inappropriate
undernutrition is that of impaired growth. The design of interventions to promote growth
demands consideration of the variance of risk of later disease across the whole distribution of
growth and size, not only that associated with shifting the population mean in what appears to
be a healthy direction in the short term.37
Approaches to interventions for improving maternal and child health have focused largely on
issues of survival, in consonance with the Millennium Development Goals for reducing
maternal and child mortality substantially by the year 2015.38 Focusing on early survival, and
on current differentials due to poverty39 and social inequalities,40 may not capture outcomes
that have longer term implications for adult health, life expectancy, quality of life, and
accumulation of human capital. Further, recommendations for nutritional interventions are
frequently based on improving birth weight, focusing on gains in stature or micronutrient
status in the short term.41 Where longer-term follow-up data are available they confirm the
existence of a window of opportunity for intervention in early childhood, under 24 months of
age, and only limited benefit, or even harm, of feeding strategies thereafter.3,42
Health is often not included in calculations of human capital other than in terms of health
expenditure, although a healthier population is an economically more productive population.
Estimates of the true accumulation of human capital embodied in an individual should include
more than the conventional economic measure of educational attainment: ideally it should
incorporate the impact of events from conception or earlier, perhaps even extending to
measures of intergenerational accrual of biological benefit.
Robust measures of economic benefit are required to persuade policymakers of the wisdom of
investing in a life-course approach to health, and we arrived at two specific recommendations.
6

First, the use of linear discount rates in assessing benefit disadvantages early life
interventions43 and has limitations when considering intergenerational equity.44 Secondly,
while utility-based measures of disease burden such as DALYs allow comparison of
intervention programmes,2 they fail to capture intergenerational benefit or the monetary value
of the ensuing savings in healthcare or increases in labour productivity. More sophisticated
composite measures of outcome are required to demonstrate the true cost-benefit ratio of early
life interventions.
The increasing prevalence of metabolic disease worldwide, with its enormous current and
projected costs, challenges a wide range of disciplines to provide an explanation of the
underlying human biology and to define the optimal ways to intervene (Table 1). Merely
focusing on genetic predisposition or improving adult lifestyle is inadequate. Disease risk
from mismatch is exacerbated by a relatively small change in nutritional conditions in
societies starting from a low baseline level, and the resulting increased susceptibility to
obesity and gestational diabetes passes risk on to the next generation. Because early growth
and development is a time in human life when substantial biological stock is transferred to
future generations,3,45 ignoring the processes by which this occurs risks erosion of future
human capital in both health and economic terms. As developmental plasticity results in
variation in human phenotype and life-course strategy, adopting a ‘one size fits all’ approach
to intervention will fail in efficacy for a percentage of the population, and may put some
individuals at greater risk of later poor health.
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Figure 1. Modes of human adaptability
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Table 1. Adaptive plasticity and human health: research agenda
Basic research
• What are the mechanisms by which early life events have long-term effects, and can the
pathway be altered or reversed?
•

What is optimal fetal development – how can it be defined in relation to later risk?

•

What are the indicators of optimal pregnancy outcome – e.g. birth size, duration of pregnancy
– and what levels of risk do they constitute?

•

To what extent could markers of specific nutrient status prior to or during pregnancy inform
about the likely outcomes of the pregnancy?

•

To what extent could postnatal epigenetic markers inform about the likely life course of the
offspring?

•

What are the postnatal windows of plasticity and therefore intervention?

•

What is the extent and mechanism of intergenerational transmission of disease risk?

Operational research
• What is the significance of developmental processes in generating the burden of disease in
different populations?
•

What approaches are possible to intervene in individuals and in populations during different
stages of the life course (preconception, pregnancy, lactation, childhood, adult, parent)?

•

How can developmental interventions be made context-specific, balancing prevention of
undernutrition against the later-life consequences of rapid postnatal weight gain?

•

What level of developmental risk of later chronic disease is acceptable?

•

How can the various levels of intervention (societal to individual) be designed appropriately
within the cultural context?

•

What are the societal costs of less than optimal development, measured with more appropriate
models than simple discounting?

•

What are the short-term and long-term economic benefits of optimizing early-life
development?

•

What is the cost-benefit ratio of early intervention?

•

Which interventions are most likely to be cost effective?
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